Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Value Health. 2020 Aug;23(8):1087-1095. doi: 10.1016/j.jval.2020.03.013. Epub 2020 Jul 15.
The increasing incidence of esophageal adenocarcinoma (EAC) and the dismal prognosis has stimulated interest in the early detection of EAC. Our objective was to determine individuals' preferences for EAC screening and to assess to what extent procedural characteristics of EAC screening tests predict willingness for screening participation.
A discrete choice experiment questionnaire was sent by postal mail to 1000 subjects aged 50 to 75 years who were randomly selected from the municipal registry in the Netherlands. Each subject answered 12 discrete choice questions of 2 hypothetical screening tests comprising 5 attributes: EAC-related mortality risk reduction, procedure-related pain and discomfort, screening location, test specificity, and costs. A multinomial logit model was used to estimate individuals' preferences for each attribute level and to calculate expected rates of uptake.
In total, 375 individuals (37.5%) completed the questionnaire. Test specificity, pain and discomfort, mortality reduction, and out-of-pocket costs all had a significant impact on respondents' preferences. The average expected uptake of EAC screening was 62.8% (95% confidence interval [CI] 61.1-64.5). Severe pain and discomfort had the largest impact on screening uptake (-22.8%; 95% CI -26.8 to -18.7). Male gender (β 2.81; P < .001), cancer worries (β 1.96; P = .01), endoscopy experience (β 1.46; P = .05), and upper gastrointestinal symptoms (β 1.50; P = .05) were significantly associated with screening participation.
EAC screening implementation should consider patient preferences to maximize screening attendance uptake. Based on our results, an optimal screening test should have high specificity, cause no or mild to moderate pain or discomfort, and result in a decrease in EAC-related mortality.
食管腺癌(EAC)发病率的上升和预后不良激发了人们对 EAC 早期检测的兴趣。我们的目的是确定个体对 EAC 筛查的偏好,并评估 EAC 筛查测试的程序特征在多大程度上预测了筛查参与意愿。
通过邮寄方式向 1000 名年龄在 50 至 75 岁之间的随机选择的荷兰市登记处的受试者发送了一份离散选择实验问卷。每位受试者回答了 12 个关于 2 种假设性筛查测试的离散选择问题,包含 5 个属性:EAC 相关死亡率降低、与程序相关的疼痛和不适、筛查地点、测试特异性和成本。使用多项逻辑回归模型来估计个体对每个属性水平的偏好,并计算预期的参与率。
总共有 375 名个体(37.5%)完成了问卷。测试特异性、疼痛和不适、死亡率降低和自付费用都对受访者的偏好产生了重大影响。EAC 筛查的平均预期参与率为 62.8%(95%置信区间[CI] 61.1-64.5)。严重疼痛和不适对筛查参与率的影响最大(-22.8%;95%CI-26.8 至-18.7)。男性(β 2.81;P<.001)、癌症担忧(β 1.96;P=.01)、内镜检查经验(β 1.46;P=.05)和上消化道症状(β 1.50;P=.05)与筛查参与显著相关。
EAC 筛查的实施应考虑患者的偏好,以最大限度地提高筛查参与率。根据我们的结果,最佳的筛查测试应该具有高特异性,不会或仅引起轻微至中度疼痛或不适,并且能够降低 EAC 相关死亡率。